Welcome to our dedicated page for Jatt Ii Acquisition SEC filings (Ticker: JATT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
JATT II Acquisition Corp filings document the regulatory record of a Cayman Islands SPAC with Nasdaq-listed ordinary shares. The company’s Form 8-K disclosures report its initial public offering, ordinary-share capitalization, material definitive agreements, underwriter over-allotment arrangements and exchange listing under the symbol JATT.
The filing record also identifies governance and issuer-status matters, including emerging growth company status, Section 12(b) registration of the ordinary shares and other public-company disclosures associated with a blank-check company pursuing a business combination.
JATT II Acquisition Corp. director Jonathon Kluft filed an initial ownership report on Form 3. The filing shows an indirect holding of 25,000 Ordinary Shares, recorded as of the reported date. These shares reflect founder-related interests received through the company’s sponsor rather than a new market transaction.
JATT II Acquisition Corp. director and Chief Financial Officer Nicholas Fernandez filed an initial ownership report showing an indirect interest in 50,000 Ordinary Shares.
According to a footnote, this interest comes through founder shares held via membership interests in the company’s sponsor, JATT Ventures II L.P., rather than directly owned stock.
JATT II Acquisition Corp. insider JATT Ventures II L.P. filed an initial Form 3 disclosing its ownership in the company’s ordinary shares. The filing reports direct ownership of 1,725,000 Ordinary Shares, establishing JATT Ventures II L.P. as a ten percent owner of the company.
The footnotes explain that JATT Ventures II Ltd is the sole general partner of JATT Ventures II L.P., and Dr. Someit Sidhu is both a limited partner of JATT Ventures II L.P. and the sole member of JATT Ventures II Ltd. Dr. Sidhu has voting and investment discretion over these shares but disclaims beneficial ownership except for any pecuniary interest.